These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7520576)
1. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia. de la Torre M; Eklöv S; Häggman M; Björk P; Busch C; Nilsson S Prostate; 1994 Sep; 25(3):125-31. PubMed ID: 7520576 [TBL] [Abstract][Full Text] [Related]
2. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate. Shiina H; Urakami S; Shirakawa H; Igawa M; Ishibe T; Usui T Eur Urol; 1996; 29(1):106-10. PubMed ID: 8821700 [TBL] [Abstract][Full Text] [Related]
3. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study. Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH Prostate; 1989; 14(1):27-43. PubMed ID: 2648345 [TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate. Bichler KH; Flüchter SH; Nelde HJ; Björk P; Müntzing J Prostate; 1989; 14(1):13-25. PubMed ID: 2467273 [TBL] [Abstract][Full Text] [Related]
5. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression. Shiina H; Igawa M; Ishibe T Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325 [TBL] [Abstract][Full Text] [Related]
6. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue. Shiina H; Sumi H; Ishibe T; Usui T Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169 [TBL] [Abstract][Full Text] [Related]
7. Clinical study on estramustine binding protein (EMBP) in human prostate. Shiina H; Igawa M; Ishibe T Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085 [TBL] [Abstract][Full Text] [Related]
8. Estramustine binding protein in human benign prostatic hypertrophy. Shiina H; Mizutani M; Ishibe T Andrologia; 1990; 22(4):309-12. PubMed ID: 1702270 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma. Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957 [TBL] [Abstract][Full Text] [Related]
10. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA. Shiina H; Ishibe T; Usui T Biochem Biophys Res Commun; 1989 Dec; 165(3):947-55. PubMed ID: 2482024 [TBL] [Abstract][Full Text] [Related]
11. Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancer. Nordgren H; Nilsson S; Eklöv S; Stattin P; Naining W; Heiden T; Bergkvist L; Karlberg L; Lundholm C; Harvig B Acta Oncol; 1991; 30(2):211-4. PubMed ID: 2029408 [TBL] [Abstract][Full Text] [Related]
13. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue. Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122 [TBL] [Abstract][Full Text] [Related]
14. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein. Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904 [TBL] [Abstract][Full Text] [Related]
15. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma. Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865 [TBL] [Abstract][Full Text] [Related]
16. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression. Björk P; Isaacs JT; Hartley-Asp B Prostate; 1991; 18(3):181-200. PubMed ID: 2020618 [TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections. Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093 [TBL] [Abstract][Full Text] [Related]
18. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features. Gabal SM; Habib FM; Helmy DO; Ibrahim MF J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287 [TBL] [Abstract][Full Text] [Related]
19. Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma. Björk P; Borg A; Fernö M; Nilsson S Anticancer Res; 1991; 11(3):1173-82. PubMed ID: 1888147 [TBL] [Abstract][Full Text] [Related]
20. Estramustine binding protein in human brain-tumor tissue. von Schoultz E; Bergenheim T; Grankvist K; Henriksson R J Neurosurg; 1991 Jun; 74(6):962-4. PubMed ID: 1709687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]